EGFR and non-small cell lung carcinoma: Approximately 88% of newly diagnosed lung cancer cases in Canada are non-small cell lung cancers (NSCLC), of which approximately 15% harbor a mutation in the epidermal growth factor receptor (EGFR) gene [2,3,4,5,6].